國立虎尾科技大學 |

Hepatitis C in developing countries : = current and future challenges /

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Hepatitis C in developing countries :/ edited by Sanaa M. Kamal.
Reminder of title:	current and future challenges /
other author:	Kamal, Sanaa M.,
Description:	1 online resource
Subject:	Hepatitis C - Developing countries. -
Online resource:	https://www.sciencedirect.com/science/book/9780128032336
ISBN:	9780128032343

Hepatitis C in developing countries : = current and future challenges /
Hepatitis C in developing countries :current and future challenges /edited by Sanaa M. Kamal. - 1 online resource

Includes bibliographical references and index.

Hepatitis C virus / Ahmed Abdel Aziz -- Epidemiology and modes of transmission of HCV in developing countries / Sanaa M. Kamal and Dahlia Ghoraba -- Public health and economic burden of Hepatitis C infection in developing countries / Tamer A. Hafez -- Social, cultural, and political factors influencing HCV in developing countries / Sara A. Abdelhakam and Mohamad A. Othman -- Hepatitis C in Egypt / Sanaa M. Kamal and Sara A. Abdelhakam -- Hepatitis C in North Africa (Arabic Maghreb region) / Mohamed A. Daw -- Hepatitis C virus in sub-saharan Africa / Osi Obadahn and Sanaa M. Kamal -- Hepatitis C virus infection in the Indian sub-continent / Shashi Shekhar -- Hepatitis C in developing countries in southeast Asia / Thi Q. Doan -- Hepatitis C and schistosomisasis coinfection / Sanaa M. Kamal -- Hepatitis C and Helminthic infections / Khalifa S. Khalifa and Othman Amin -- Hepatitis C and HIV coinfection in developing countries / Ozlem Tastan Bishop -- Hepatiis B and C coinfection / Georgios Zacharakis -- Hepatitis C infection in patients with hemogloinopathies / Sanaa M.Kamal and Ahmed M. Fouad -- Hepatitis C in patients on hemodialysis / Tamer A. Hafez -- Hepatitis C screening and diagnosis in developing countries / Huda H. Gaafar -- Hepatitis C treatment in the era of direct-acting antiviral agents / Sanaa M. Kamal.

"Hepatitis C in Developing Countries: Current and Future Challenges explores the current state of HCV in several countries, including Africa, Asia and South America. It maintains a dedicated focus on the epidemiology, clinical patterns, virologic diversity, coinfections, natural history and progression, complications, and response to standard of care (SOC) pegylated interferon and ribavirin therapy of HCV with recommendations specific to middle and low income countries. Readers will find detailed information on the burden of HCV infection from a global health and economic perspective, along with data from multicenter trials on DAAs that have enrolled patients infected with HCV non-genotype 1.Features coverage on the prevention of, or inhibition of, liver fibrosis, cirrhosis, and hepatocellular carcinomaPresents data from trials on patients with diverse ethnic backgrounds and those infected with genotypes 3, 4, 5, 6Addresses the epidemiology, modes of transmission, socio-political aspects, genotypes, and co-infections of Hepatitis C"--

ISBN: 9780128032343Subjects--Topical Terms:

1237723
Hepatitis C
--Developing countries.Index Terms--Genre/Form:

554714
Electronic books.

LC Class. No.: RC848.H425

Dewey Class. No.: 616.3623/00917/4

Hepatitis C in developing countries : = current and future challenges /
LDR:03528cam a2200301 i 4500 001 949022
006 m o d
007 cr cnu|||unuuu
008 200620s2018 enk ob 001 0 eng d
020 $a 9780128032343 $q (electronic bk.)
020 $a 0128032340 $q (electronic bk.)
020 $a 9780128032336
035 $a (OCoLC)1013462524 $z (OCoLC)1013521004 $z (OCoLC)1031874584
035 $a els69900465
040 $a N$T $b eng $e rda $e pn $c N$T $d N$T $d OPELS $d UAB $d IDEBK $d OCLCF $d MERER $d YDX $d UPM $d OCLCQ $d D6H $d DKU $d CASUM $d OCLCO
041 0 $a eng
043 $a d------
050 4 $a RC848.H425
082 0 4 $a 616.3623/00917/4 $2 23
245 0 0 $a Hepatitis C in developing countries : $b current and future challenges / $c edited by Sanaa M. Kamal.
264 1 $a London, United Kingdom : $b Academic Press is an imprint of Elsevier, $c [2018]
300 $a 1 online resource
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
504 $a Includes bibliographical references and index.
505 0 $a Hepatitis C virus / Ahmed Abdel Aziz -- Epidemiology and modes of transmission of HCV in developing countries / Sanaa M. Kamal and Dahlia Ghoraba -- Public health and economic burden of Hepatitis C infection in developing countries / Tamer A. Hafez -- Social, cultural, and political factors influencing HCV in developing countries / Sara A. Abdelhakam and Mohamad A. Othman -- Hepatitis C in Egypt / Sanaa M. Kamal and Sara A. Abdelhakam -- Hepatitis C in North Africa (Arabic Maghreb region) / Mohamed A. Daw -- Hepatitis C virus in sub-saharan Africa / Osi Obadahn and Sanaa M. Kamal -- Hepatitis C virus infection in the Indian sub-continent / Shashi Shekhar -- Hepatitis C in developing countries in southeast Asia / Thi Q. Doan -- Hepatitis C and schistosomisasis coinfection / Sanaa M. Kamal -- Hepatitis C and Helminthic infections / Khalifa S. Khalifa and Othman Amin -- Hepatitis C and HIV coinfection in developing countries / Ozlem Tastan Bishop -- Hepatiis B and C coinfection / Georgios Zacharakis -- Hepatitis C infection in patients with hemogloinopathies / Sanaa M.Kamal and Ahmed M. Fouad -- Hepatitis C in patients on hemodialysis / Tamer A. Hafez -- Hepatitis C screening and diagnosis in developing countries / Huda H. Gaafar -- Hepatitis C treatment in the era of direct-acting antiviral agents / Sanaa M. Kamal.
520 $a "Hepatitis C in Developing Countries: Current and Future Challenges explores the current state of HCV in several countries, including Africa, Asia and South America. It maintains a dedicated focus on the epidemiology, clinical patterns, virologic diversity, coinfections, natural history and progression, complications, and response to standard of care (SOC) pegylated interferon and ribavirin therapy of HCV with recommendations specific to middle and low income countries. Readers will find detailed information on the burden of HCV infection from a global health and economic perspective, along with data from multicenter trials on DAAs that have enrolled patients infected with HCV non-genotype 1.Features coverage on the prevention of, or inhibition of, liver fibrosis, cirrhosis, and hepatocellular carcinomaPresents data from trials on patients with diverse ethnic backgrounds and those infected with genotypes 3, 4, 5, 6Addresses the epidemiology, modes of transmission, socio-political aspects, genotypes, and co-infections of Hepatitis C"-- $c Provided by publisher.
650 0 $a Hepatitis C $z Developing countries. $3 1237723
650 1 2 $a Hepatitis C. $3 788667
650 2 2 $a Developing Countries. $3 567210
650 2 2 $a Hepacivirus. $3 1237724
655 4 $a Electronic books. $2 local $3 554714
700 1 $a Kamal, Sanaa M., $e editor. $3 1237722
856 4 0 $u https://www.sciencedirect.com/science/book/9780128032336